|
SERF1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.205970E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.494100E-02 |
| Normal-vs-Stage2 |
9.572200E-01 |
| Normal-vs-Stage3 |
5.156700E-03 |
| Normal-vs-Stage4 |
1.350730E-04 |
| Stage1-vs-Stage2 |
1.347380E-01 |
| Stage1-vs-Stage3 |
1.607230E-01 |
| Stage1-vs-Stage4 |
5.923900E-03 |
| Stage2-vs-Stage3 |
2.800400E-02 |
| Stage2-vs-Stage4 |
3.155600E-03 |
| Stage3-vs-Stage4 |
2.304200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.021700E-03 |
| Normal-vs-AfricanAmerican |
1.251830E-01 |
| Normal-vs-Asian |
4.955900E-02 |
| Caucasian-vs-AfricanAmerican |
9.474600E-01 |
| Caucasian-vs-Asian |
7.495600E-01 |
| AfricanAmerican-vs-Asian |
8.093000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.408800E-04 |
| Normal-vs-Female |
6.402300E-02 |
| Male-vs-Female |
8.941200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.011900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.030200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.276200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.661200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.517000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.419200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.906400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.943400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.809600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.969000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.619300E-03 |
| Classical-VS-Follicular |
6.38020000054418E-07 |
| Classical-VS-Other |
9.018000E-01 |
| Classical-VS-Normal |
4.835800E-03 |
| Tall-VS-Follicular |
2.67470001702463E-09 |
| Tall-VS-Other |
1.697960E-01 |
| Tall-VS-Normal |
3.76020000003585E-06 |
| Follicular-VS-Other |
9.010400E-02 |
| Follicular-VS-Normal |
8.904000E-02 |
| Other-VS-Normal |
1.532580E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.340800E-01 |
| Normal-vs-N1 |
7.566700E-04 |
| N0-vs-N1 |
3.718400E-03 |
|
|
